Home › Pancreatic Ductal Carcinoma › Pennsylvania
Pancreatic Ductal Carcinoma clinical trials in Pennsylvania
3 studies for Pancreatic Ductal Carcinoma are looking for participants at sites in Pennsylvania.
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Hospital of the University of Pennsylvania, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Allegheny Health Network, Pittsburgh
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
- Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia
- Allegheny General Hospital, Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06850623From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.